Allogene Therapeutics
ALLO
ALLO
86 hedge funds and large institutions have $1.88B invested in Allogene Therapeutics in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.23% more ownership
Funds ownership: 51.6% → 53.83% (+2.2%)
21% less call options, than puts
Call options by funds: $2.45M | Put options by funds: $3.11M
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
86
Holding in Top 10
3
Calls
$2.45M
Puts
$3.11M
Top Buyers
| 1 | +$37.1M | |
| 2 | +$24.1M | |
| 3 | +$22.3M | |
| 4 |
BII
Bainco International Investors
Boston,
Massachusetts
|
+$10.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$8.5M |
Top Sellers
| 1 | -$19.1M | |
| 2 | -$16.6M | |
| 3 | -$4.6M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$4.12M |
| 5 |
SC
Samlyn Capital
New York
|
-$4.04M |